Background and Format: Launched in 2003, Medical News Today is a website overseen by Healthline Media UK Ltd and is aimed at healthcare professionals and consumers. Covers health news, diseases, nutrition & diet and pain & aesthetics. For more information about advertising rates, the team can be reached here. Circulation: Source: Publisher.

ASH Clinical News is a news publication from the American Society of Hematology and serves as a source for worldwide news and perspectives on hematology and oncology. Coverage includes blood disorders and related topics of interest to hematologists, including developments in oncology, endocrinology and cardiology. Each month it provides the latest updates in the field along with perspectives and opinions from key leaders as well as tools and resources to help clinicians with quality and performance improvement, patient education, and the economics of running a practice.

Impact factor: 4.411 (Thomson Reuters, 2016) Journal Ranking: 48/213  (Oncology) (Thomson Reuters, 2016) Affiliations: Blood Cancer Journal is a sister journal to Leukemia. Aims of the journal: Blood Cancer Journal is a peer-reviewed, online, open access, sister journal to Leukemia. The journal aims to bring the fore outstanding pre-clinical and clinical research in the field of hematology, with ramifications into translational biology research down to new therapies. Contents: Topics of particular concentration will include, but are not limited to, the following: Careful analysis of validation of in-vitro experimentations of new compounds devoted to phase 1 studies Murine models Therapies such as specific inhibitory molecules, antibodies, immunotherapy manipulations Editorial contacts: Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the editorial office at bcj@nature.com Manuscript Submission: Instructions for Authors can be found here. Online submission at http://mts-bcj.nature.com/cgi-bin/main.plex

Edited for practicing hematologists, oncologists and hem/onc specialists with an emphasis on diagnosis, treatment and pharmacology. Content offers news on clinical developments in the field and includes a practice management section covering malpractice, legislative changes and socioeconomic issues. Covers clinical news in hematology and oncology. Contains the most up-to-date news in both oncology and hematology, including topics in non-malignant blood disorders, such as lupus, anemia and clotting disorders. While the emphasis is on diagnosis, treatment and pharmacology, the practice management section presents information on malpractice, legislative and socioeconomic topics of interest to hematologists and oncologists. Features news articles, commentary, news notes, letters to the editor, product news, meetings and courses, practice management, Washington update, legal affairs, News You Can Eat, final consult, virtual digest, point and counter point, pharmacology consult, What's Your Diagnosis and special reports.

Impact factor: 3.093 Journal ranking: 28/68 (Hematology), 103/211 (Oncology) (Source: Thomson Reuters Journal Citation Reports 2014) Circulation: The Publisher does not disclose the circulation. Frequency: 12 issues per year. Aims of the journal: Leukemia & Lymphoma is an international journal that publishes full-length papers and reviews on clinical and therapeutic practice, epidemiological studies and outcomes analysis, laboratory diagnosis, pathology, cytology, ultrastructure, cytogenetics and cellular and molecular immunology of hematologic malignancies; the journal aims at a strong clinical-pathologic correlation. Letters and correspondence to the editors are also accepted on all topics, which are novel and provide new and interesting data for clinicians and postgraduate teaching. In addition, an update is provided on the basic issues and advances in molecular genetics as applied to this field. The journal aims to provide an important reference source for physicians and scientists who deal essentially with the clinical and laboratory diagnosis, clinical care and therapy of patients with these disorders. Content: Leukemia & Lymphoma publishes the following types of articles: Original Articles (Clinical and Research) - are reports whose conclusions represent a substantial advance in the understanding of an important problem. Review Articles - survey recent developments in topical areas of scientific research and clinical practice or, on occasion, more wide-ranging subjects. Review articles are mostly invited. Letter to the Editor - Brief research observations and clinical studies should be submitted in this format. While reports of individual cases with unique scientific or educational value, which impact and enhance clinical practice or diagnostic understanding will be considered, the Journal no longer has a separate section on case reports. Accepted case reports in the correct format will only be published as Letters to the Editor. All submissions in this category should not contain an abstract and the text must run continuously in the style of a Letter without any divisions into separate sections (there should be no headings such as introduction, methods, results or discussion). Correspondence - are short comments from readers either related to previously published articles in the journal or topical / controversial issues in the field. Editorials - are invited, short opinion articles on pertinent and / or controversial topics. Commentaries - are invited, short commentaries on articles published in the journal. Editorial contacts: A full editorial board can be viewed here. Manuscript submission: Instructions for Authors can be viewed here. Online manuscript submissions can be made online here. Ad rates: Information on advertising can be found here